Physician profile
David K Bailey
NPI 1598868788
$5,529.97
in general payments reported to CMS, 2019-2025
11 companies · $1,001 in 2025
The $1,001 reported for 2025 was more than what 91% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $816 · 2020: $181 · 2021: $403 · 2022: $661 · 2023: $1,254 · 2024: $1,214 · 2025: $1,001.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,469.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,469.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $3,312.94 | 2022-2025 | Infuse, Biotrue One Day, Ultra Multifocal Toric |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $935.53 | 2019-2021 | |
| Coopervision INC. | $455.06 | 2019-2025 | Clariti Contact Lens, Misight Contact Lens |
| Alcon Vision LLC | $314.65 | 2023-2025 | Precision 1, Total30, Hydrus Microstent |
| Allergan, INC. | $162.74 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $92.14 | 2019-2023 | Cequa |
| Lkc Technologies, INC. | $83.34 | 2023 | |
| Abbvie INC. | $79.39 | 2023-2025 | Vuity, Lumigan, Alphagan P |
| Optos, INC. | $64.78 | 2019 | |
| Kala Pharmaceuticals, INC. | $17.57 | 2022 | |
| Shire North American Group INC | $11.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.